Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals – Carrier is inorganic
Patent
1995-05-09
1998-07-21
Chin, Christopher L.
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
Carrier is inorganic
424 129, 424 149, 424 153, 424417, 424420, 424422, 424423, 424428, 424429, 424490, 4241811, 427214, 6048901, 6048911, 604 4, 604 5, 604 6, G01N 33553
Patent
active
057834547
ABSTRACT:
The invention provides a method for making a selenium-carrier conjugate by covalently attaching (i) an organic selenium compound selected from the group consisting of RSeH, RSeR, RSeR', RSeSeR and RSeSeR', wherein R and R' are each an aliphatic residue containing at least one reactive group selected from the group consisting of aldehyde, amino, alcoholic, phosphate, sulfate, halogen or phenolic reactive groups and combinations thereof, to (ii) a carrier having a constituent capable of forming a covalent bond with said reactive groups of said selenium compound to produce a selenium-carrier conjugate which is capable of specific attachment to a target site. The carrier may be a protein, such as an antibody specific to a bacteria, virus, protozoa, or cell antigen, including without limitation, cell surface antigens, a peptide, carbohydrate, lipid, vitamin, drug, lectin, plasmid, liposome, nucleic acid or a non-metallic implantable device, such as an intraocular implant or a vascular shunt. The attachment of selenium compounds of the configurations described above to carriers when presented to either endogenous thiols, such as glutathione which occurs in all aerobic living cells, or exogenous thiols, such as glutathione or cysteine, produces superoxide (O.sub.2.sup..-), hydrogen peroxide, the hydroxyl radical (.sup.. OH) and other cytotoxic reactive oxygen species so as to collectively form a localized free radical pharmacology based upon the catalytic selenium anion, RSe.sup.-.
REFERENCES:
patent: 4166820 (1979-09-01), Spallholz
patent: 4341757 (1982-07-01), Spallholz
patent: 4584277 (1986-04-01), Spallholz
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4937183 (1990-06-01), Ultee et al.
patent: 5057313 (1991-10-01), Shih et al.
patent: 5104852 (1992-04-01), Kralick et al.
patent: 5225182 (1993-07-01), Sharma
Biochem. Pharmacol., vol. 1. 45, No. 2, 26 Jan. 1993, pp. 429-437, Yan L. et al. "Generation of Reactive Oxygen Species from the Reaction of Selenium Compounds with Thiols and Mammary Tumor Cells." see p. 429, col. 2.
Chemical Abstracts, vol. 112, No. 17, 23 Apr. 1990, Columbus, Ohio, US; abstract No. 151194, Nomura, H. et al. "Binding of ebselen to plasma (1989) , Meeeting Date 1988, 189-93. Editor(s): Wendel,Albrecht. Publisher: Springer, Berlin, Fed. Rep. Ger. Coden 56SMAT, 1989.
Chemical Abstracts, vol. 120, No. 21, 23 May 1994, Columbus, OH US; abstract No. 260711, Shenberg, Cesia et al "An XRF study of trace elements accumulation in kidneys of tumor-bearing mice after treatent with cis-DDP with the without selemnite ans selenocystamie" see abstract & Biol. Trace Elem. Res. (1994), 40(2), 137-49 Coden: BTERDG; ISSN: 0163-4984, 1994.
Chemical Abstracts, vol. 115, No. 17, 28 Oct. 1991, Columbus, OH, US; abstract No. 181934; Yan Lin et al "Effect of selenium compounds and thiols on human mammary tumor cells" see abstract & Biol. Trace Elem. Res/ (1991), 30(2), 145-62 Coden: BTERDG: ISSN: 0163-4984, 1991.
Reid Ted W.
Spallholz Julian E.
Chin Christopher L.
Nguyen Bao-Thuy L.
LandOfFree
Method for the preparation of free radical pharmaceuticals using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the preparation of free radical pharmaceuticals using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the preparation of free radical pharmaceuticals using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1646295